Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

The secret life of nonclassical monocytes.

Marsh SA, Arthur HM, Spyridopoulos I.

Cytometry A. 2017 Nov;91(11):1055-1058. doi: 10.1002/cyto.a.23280. Epub 2017 Oct 27. No abstract available.

2.

The native microbiome of the nematode Caenorhabditis elegans: gateway to a new host-microbiome model.

Dirksen P, Marsh SA, Braker I, Heitland N, Wagner S, Nakad R, Mader S, Petersen C, Kowallik V, Rosenstiel P, Félix MA, Schulenburg H.

BMC Biol. 2016 May 9;14:38. doi: 10.1186/s12915-016-0258-1.

3.

Evidence for distinct effects of exercise in different cardiac hypertrophic disorders.

Johnson EJ, Dieter BP, Marsh SA.

Life Sci. 2015 Feb 15;123:100-6. doi: 10.1016/j.lfs.2015.01.007. Epub 2015 Jan 26. Review.

4.

Altering the redox state of skeletal muscle by glutathione depletion increases the exercise-activation of PGC-1α.

Strobel NA, Matsumoto A, Peake JM, Marsh SA, Peternelj TT, Briskey D, Fassett RG, Coombes JS, Wadley GD.

Physiol Rep. 2014 Dec 23;2(12). pii: e12224. doi: 10.14814/phy2.12224. Print 2014 Dec 1.

5.

The role of O-GlcNAc transferase in regulating the gene transcription of developing and failing hearts.

Medford HM, Marsh SA.

Future Cardiol. 2014 Nov;10(6):801-12. doi: 10.2217/fca.14.42. Review.

6.

O-GlcNAc protein modification in C2C12 myoblasts exposed to oxidative stress indicates parallels with endogenous antioxidant defense.

Peternelj TT, Marsh SA, Morais C, Small DM, Dalbo VJ, Tucker PS, Coombes JS.

Biochem Cell Biol. 2015 Feb;93(1):63-73. doi: 10.1139/bcb-2014-0106. Epub 2014 Oct 8.

PMID:
25453190
7.

Glutathione depletion and acute exercise increase O-GlcNAc protein modification in rat skeletal muscle.

Peternelj TT, Marsh SA, Strobel NA, Matsumoto A, Briskey D, Dalbo VJ, Tucker PS, Coombes JS.

Mol Cell Biochem. 2015 Feb;400(1-2):265-75. doi: 10.1007/s11010-014-2283-0. Epub 2014 Nov 23.

PMID:
25416863
8.

A new system for profiling drug-induced calcium signal perturbation in human embryonic stem cell-derived cardiomyocytes.

Lewis KJ, Silvester NC, Barberini-Jammaers S, Mason SA, Marsh SA, Lipka M, George CH.

J Biomol Screen. 2015 Mar;20(3):330-40. doi: 10.1177/1087057114557232. Epub 2014 Nov 3.

9.

Protein O-GlcNAcylation and cardiovascular (patho)physiology.

Marsh SA, Collins HE, Chatham JC.

J Biol Chem. 2014 Dec 12;289(50):34449-56. doi: 10.1074/jbc.R114.585984. Epub 2014 Oct 21. Review.

10.

High-fat, low-carbohydrate diet promotes arrhythmic death and increases myocardial ischemia-reperfusion injury in rats.

Liu J, Wang P, Zou L, Qu J, Litovsky S, Umeda P, Zhou L, Chatham J, Marsh SA, Dell'Italia LJ, Lloyd SG.

Am J Physiol Heart Circ Physiol. 2014 Aug 15;307(4):H598-608. doi: 10.1152/ajpheart.00058.2014. Epub 2014 Jun 13.

11.

A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes.

Cox EJ, Marsh SA.

PLoS One. 2014 Mar 24;9(3):e92903. doi: 10.1371/journal.pone.0092903. eCollection 2014. Review.

12.

Consuming a Western diet for two weeks suppresses fetal genes in mouse hearts.

Medford HM, Cox EJ, Miller LE, Marsh SA.

Am J Physiol Regul Integr Comp Physiol. 2014 Apr 15;306(8):R519-26. doi: 10.1152/ajpregu.00253.2013. Epub 2014 Feb 12.

13.

A novel protocol for assessing exercise performance and dystropathophysiology in the mdx mouse.

Rocco AB, Levalley JC, Eldridge JA, Marsh SA, Rodgers BD.

Muscle Nerve. 2014 Oct;50(4):541-8. doi: 10.1002/mus.24184. Epub 2014 Aug 5.

PMID:
24449511
14.
15.

Immediate effects of a single exercise bout on protein O-GlcNAcylation and chromatin regulation of cardiac hypertrophy.

Medford HM, Porter K, Marsh SA.

Am J Physiol Heart Circ Physiol. 2013 Jul 1;305(1):H114-23. doi: 10.1152/ajpheart.00135.2013. Epub 2013 Apr 26.

16.

Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes.

Zhu-Mauldin X, Marsh SA, Zou L, Marchase RB, Chatham JC.

J Biol Chem. 2012 Nov 9;287(46):39094-106. doi: 10.1074/jbc.M112.383778. Epub 2012 Sep 19.

17.

Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart.

McLarty JL, Marsh SA, Chatham JC.

Life Sci. 2013 Mar 28;92(11):621-7. doi: 10.1016/j.lfs.2012.08.006. Epub 2012 Aug 11. Review.

18.

Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart.

Marsh SA, Powell PC, Dell'italia LJ, Chatham JC.

Life Sci. 2013 Mar 28;92(11):648-56. doi: 10.1016/j.lfs.2012.06.011. Epub 2012 Jun 20.

19.

Chronic ingestion of a Western diet increases O-linked-β-N-acetylglucosamine (O-GlcNAc) protein modification in the rat heart.

Medford HM, Chatham JC, Marsh SA.

Life Sci. 2012 Jun 14;90(23-24):883-8. doi: 10.1016/j.lfs.2012.04.030. Epub 2012 Apr 30.

20.

Effects of exercise training and RhoA/ROCK inhibition on plaque in ApoE-/- mice.

Matsumoto A, Manthey HD, Marsh SA, Fassett RG, de Haan JB, Rolfe BE, Coombes JS.

Int J Cardiol. 2013 Aug 20;167(4):1282-8. doi: 10.1016/j.ijcard.2012.03.172. Epub 2012 Apr 22.

PMID:
22525349
21.

Heart smart insulin-like growth factor 1.

Marsh SA, Davidoff AJ.

Hypertension. 2012 Mar;59(3):550-1. doi: 10.1161/HYPERTENSIONAHA.111.188441. Epub 2012 Jan 23. No abstract available.

PMID:
22275529
22.

Cardioprotection requires flipping the 'posttranslational modification' switch.

Porter K, Medford HM, McIntosh CM, Marsh SA.

Life Sci. 2012 Jan 16;90(3-4):89-98. doi: 10.1016/j.lfs.2011.10.026. Epub 2011 Dec 3. Review.

PMID:
22154907
23.

Importance of understanding pre-analytical variability in biomarker development.

Strobel NA, Fassett RG, Marsh SA, Coombes JS.

Int J Cardiol. 2011 Jul 15;150(2):223-4. doi: 10.1016/j.ijcard.2011.05.014. Epub 2011 Jun 12. No abstract available.

PMID:
21658784
24.

Effects of exercise and antioxidant supplementation on endothelial gene expression.

Matsumoto A, Mason SR, Flatscher-Bader T, Ward LC, Marsh SA, Wilce PA, Fassett RG, de Haan JB, Coombes JS.

Int J Cardiol. 2012 Jun 28;158(1):59-65. doi: 10.1016/j.ijcard.2010.12.104. Epub 2011 Feb 4.

PMID:
21295869
25.

The paradoxical world of protein O-GlcNAcylation: a novel effector of cardiovascular (dys)function.

Marsh SA, Chatham JC.

Cardiovasc Res. 2011 Feb 15;89(3):487-8. doi: 10.1093/cvr/cvq405. Epub 2010 Dec 21. No abstract available.

26.

Antioxidant supplementation reduces skeletal muscle mitochondrial biogenesis.

Strobel NA, Peake JM, Matsumoto A, Marsh SA, Coombes JS, Wadley GD.

Med Sci Sports Exerc. 2011 Jun;43(6):1017-24. doi: 10.1249/MSS.0b013e318203afa3.

PMID:
21085043
27.

Oxidative stress biomarkers as predictors of cardiovascular disease.

Strobel NA, Fassett RG, Marsh SA, Coombes JS.

Int J Cardiol. 2011 Mar 3;147(2):191-201. doi: 10.1016/j.ijcard.2010.08.008. Review.

PMID:
20864194
28.

Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.

Laczy B, Marsh SA, Brocks CA, Wittmann I, Chatham JC.

Am J Physiol Heart Circ Physiol. 2010 Nov;299(5):H1715-27. doi: 10.1152/ajpheart.00337.2010. Epub 2010 Sep 10.

29.

Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.

Marsh SA, Dell'Italia LJ, Chatham JC.

Amino Acids. 2011 Mar;40(3):819-28. doi: 10.1007/s00726-010-0699-8. Epub 2010 Jul 30.

30.

Distribution, metabolism, and excretion of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in dogs.

Yancey MF, Merritt DA, White JA, Marsh SA, Locuson CW.

J Vet Pharmacol Ther. 2010 Apr;33(2):154-61. doi: 10.1111/j.1365-2885.2009.01120.x.

PMID:
20444040
31.

Interaction of diet and diabetes on cardiovascular function in rats.

Marsh SA, Dell'italia LJ, Chatham JC.

Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H282-92. doi: 10.1152/ajpheart.00421.2008. Epub 2008 Nov 26.

32.

A collaborative Canadian-United Kingdom evaluation of an immunohistochemistry protocol to diagnose bovine spongiform encephalopathy.

Manning L, O'Rourke KI, Knowles DP, Marsh SA, Spencer YI, Moffat E, Wells GA, Czub S.

J Vet Diagn Invest. 2008 Jul;20(4):504-8.

PMID:
18599859
33.

Developmental changes in human liver CYP2D6 expression.

Stevens JC, Marsh SA, Zaya MJ, Regina KJ, Divakaran K, Le M, Hines RN.

Drug Metab Dispos. 2008 Aug;36(8):1587-93. doi: 10.1124/dmd.108.021873. Epub 2008 May 12.

PMID:
18474679
34.
35.

Cardiovascular dysfunction in Zucker obese and Zucker diabetic fatty rats: role of hydronephrosis.

Marsh SA, Powell PC, Agarwal A, Dell'Italia LJ, Chatham JC.

Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H292-8. Epub 2007 Mar 9.

36.

Effects of antioxidant supplementation and exercise training on erythrocyte antioxidant enzymes.

Marsh SA, Laursen PB, Coombes JS.

Int J Vitam Nutr Res. 2006 Sep;76(5):324-31.

PMID:
17245671
37.
38.
39.
40.

Exercise and the endothelial cell.

Marsh SA, Coombes JS.

Int J Cardiol. 2005 Mar 18;99(2):165-9. Review.

PMID:
15749171
41.

Bcl-2 in endothelial cells is increased by vitamin E and alpha-lipoic acid supplementation but not exercise training.

Marsh SA, Laursen PB, Pat BK, Gobe GC, Coombes JS.

J Mol Cell Cardiol. 2005 Mar;38(3):445-51.

PMID:
15733904
42.

Alpha-lipoic acid does not acutely affect resistance and conduit artery function or oxidative stress in healthy men.

Sharman JE, Gunaruwan P, Knez WL, Schmitt M, Marsh SA, Wilson GR, Cockcroft JR, Coombes JS.

Br J Clin Pharmacol. 2004 Sep;58(3):243-8.

43.

Developmental expression of human hepatic CYP2C9 and CYP2C19.

Koukouritaki SB, Manro JR, Marsh SA, Stevens JC, Rettie AE, McCarver DG, Hines RN.

J Pharmacol Exp Ther. 2004 Mar;308(3):965-74. Epub 2003 Nov 21.

PMID:
14634042
44.

Mechanism-based inactivation of cytochrome P450 2B6 by a novel terminal acetylene inhibitor.

Fan PW, Gu C, Marsh SA, Stevens JC.

Drug Metab Dispos. 2003 Jan;31(1):28-36.

PMID:
12485950
45.
46.

Microspike function in cell aggregation.

Marsh SA, Jones GE.

Eur J Cell Biol. 1982 Oct;28(2):278-80. No abstract available.

PMID:
7173226

Supplemental Content

Loading ...
Support Center